Annual Cash & Cash Equivalents
$42.31 M
-$547.95 M-92.83%
December 31, 2022
Summary
- As of February 10, 2025, RETA annual cash & cash equivalents is $42.31 million, with the most recent change of -$547.95 million (-92.83%) on December 31, 2022.
- During the last 3 years, RETA annual cash & cash equivalents has fallen by -$622.01 million (-93.63%).
Performance
RETA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$48.84 M
-$36.10 M-42.50%
June 30, 2023
Summary
- As of February 10, 2025, RETA quarterly cash and cash equivalents is $48.84 million, with the most recent change of -$36.10 million (-42.50%) on June 30, 2023.
- Over the past year, RETA quarterly cash and cash equivalents has dropped by -$98.31 million (-66.81%).
Performance
RETA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RETA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -92.8% | -66.8% |
| 3 y3 years | -93.6% | -92.0% |
| 5 y5 years | -67.4% | -64.8% |
RETA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -92.8% | at low | -91.7% | -34.7% |
| 5 y | 5-year | -94.8% | at low | -94.0% | -34.7% |
| alltime | all time | -94.8% | -0.7% | -94.0% | -34.7% |
Reata Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $48.84 M(-42.5%) |
| Mar 2023 | - | $84.94 M(+100.7%) |
| Dec 2022 | $42.31 M(-92.8%) | $42.31 M(+32.6%) |
| Sep 2022 | - | $31.92 M(-78.3%) |
| Jun 2022 | - | $147.15 M(-72.3%) |
| Mar 2022 | - | $531.98 M(-9.9%) |
| Dec 2021 | $590.26 M(-27.9%) | $590.26 M(-17.2%) |
| Sep 2021 | - | $713.21 M(-5.6%) |
| Jun 2021 | - | $755.71 M(-2.8%) |
| Mar 2021 | - | $777.62 M(-5.0%) |
| Dec 2020 | $818.15 M(+23.2%) | $818.15 M(+41.5%) |
| Sep 2020 | - | $578.26 M(-5.3%) |
| Jun 2020 | - | $610.42 M(-2.3%) |
| Mar 2020 | - | $624.49 M(-6.0%) |
| Dec 2019 | $664.32 M | $664.32 M(+176.6%) |
| Sep 2019 | - | $240.15 M(-14.4%) |
| Jun 2019 | - | $280.45 M(-10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $313.06 M(-7.3%) |
| Dec 2018 | $337.79 M(+160.3%) | $337.79 M(-10.0%) |
| Sep 2018 | - | $375.19 M(+170.5%) |
| Jun 2018 | - | $138.68 M(+30.9%) |
| Mar 2018 | - | $105.94 M(-18.4%) |
| Dec 2017 | $129.78 M(+53.2%) | $129.78 M(-16.1%) |
| Sep 2017 | - | $154.60 M(+137.2%) |
| Jun 2017 | - | $65.18 M(-21.2%) |
| Mar 2017 | - | $82.68 M(-2.4%) |
| Dec 2016 | $84.73 M(+101.7%) | $84.73 M(-11.4%) |
| Sep 2016 | - | $95.66 M(+3.6%) |
| Jun 2016 | - | $92.36 M(+120.7%) |
| Mar 2016 | - | $41.85 M(-0.4%) |
| Dec 2015 | $42.01 M(-52.1%) | $42.01 M(-23.7%) |
| Sep 2015 | - | $55.05 M(-37.3%) |
| Dec 2014 | $87.76 M(-50.3%) | $87.76 M |
| Dec 2013 | $176.53 M | - |
FAQ
- What is Reata Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Reata Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Reata Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of RETA is $42.31 M
What is the all time high annual cash & cash equivalents for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high annual cash & cash equivalents is $818.15 M
What is Reata Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, RETA annual cash & cash equivalents has changed by -$547.95 M (-92.83%)
What is Reata Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RETA is $48.84 M
What is the all time high quarterly cash and cash equivalents for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high quarterly cash and cash equivalents is $818.15 M
What is Reata Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, RETA quarterly cash and cash equivalents has changed by -$98.31 M (-66.81%)